SOPHiA GENETICS (SOPH) Share-based Compensation (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Share-based Compensation data on file, last reported at $3.9 million in Q4 2025.

• For the quarter ending Q4 2025, Share-based Compensation fell 23.83% year-over-year to $3.9 million; the trailing twelve-month figure through Dec 2025 stood at $16.2 million (down 1.72% YoY), and the FY2025 full-year result was $16.2 million, down 1.72% from the prior year.
• Share-based Compensation slipped to $3.9 million in Q4 2025, from $4.1 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $5.1 million in Q4 2024 to a low of $639000.0 in Q1 2021.
• A 5-year average of $3.5 million and a median of $3.8 million in 2024 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation surged 897.26% in 2021 and fell 29.99% in 2023, its largest moves.
• Tracing SOPH's Share-based Compensation over 5 years: stood at $3.6 million in 2021, then dropped by 28.68% to $2.6 million in 2022, then surged by 62.02% to $4.2 million in 2023, then rose by 20.73% to $5.1 million in 2024, then dropped by 23.83% to $3.9 million in 2025.
• Business Quant data shows SOPH's Share-based Compensation at $3.9 million in Q4 2025, $4.1 million in Q3 2025, and $4.4 million in Q2 2025.